NCT04478123 · OUTCOME
Number of Platelet Transfusions Per Participant Issued During the AHCT Admission
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- number of platelet transfusions per pt
- Interval / dispersion
- Full Range
- Time frame
- up to 100 days from AHCT
Groups in this outcome
Romiplostim
Patients will be enrolled prior to admission for High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT), and they will undergo their planned HDT-AHCT for their respective hematologic malignancy as per institutional standards.
| Group | Source count |
|---|---|
| Romiplostim | 59 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Romiplostim | 2 | Not reported | 0 | 7 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0
- upper Limit
- 7
- value
- 2
- denoms
- counts
- group Id
- OG000
- value
- 59
- units
- Participants
- dispersion Type
- Full Range
- groups
- description
- Patients will be enrolled prior to admission for High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT), and they will undergo their planned HDT-AHCT for their respective hematologic malignancy as per institutional standards.
- id
- OG000
- title
- Romiplostim
- param Type
- MEDIAN
- reporting Status
- POSTED
- time Frame
- up to 100 days from AHCT
- title
- Number of Platelet Transfusions Per Participant Issued During the AHCT Admission
- type
- SECONDARY
- unit Of Measure
- number of platelet transfusions per pt
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle